- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02528162
Evaluation of Education for Gestational Diabetes
November 3, 2020 updated by: Universitaire Ziekenhuizen KU Leuven
Evaluation of Knowledge Regarding Gestational Diabetes and Evaluation of (Group) Education for Gestational Diabetes
Prospective observational cohort study of women with gestational diabetes (GDM) based on the 'International Association of Pregnancy Study Groups' (IADPSG) criteria.
The overall aim is to evaluate the knowledge regarding GDM of women with GDM and to evaluate the satisfaction of women with GDM about the education they receive (given in group or individually).
Normal routine care is followed and evaluated.
Study Overview
Study Type
Observational
Enrollment (Actual)
200
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Leuven, Belgium, 3000
- UZ Leuven
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 45 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
Women diagnosed with GDM based on the IADPSG criteria
Description
Inclusion Criteria:
- Women ≥ 18 years diagnosed with GDM in the university hospital Leuven.
Exclusion Criteria:
- Women who received bariatric surgery.
- Women with pregestational diabetes or diagnosed with diabetes during early pregnancy.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Evaluation of the knowledge regarding GDM with a self-designed questionnaire
Time Frame: over a 2-4 week period
|
over a 2-4 week period
|
|
Scale (0 to 3) with questionnaire on depression (CES-D )
Time Frame: over a 2-4 week period
|
over a 2-4 week period
|
|
Evaluation of satisfaction with education and Diabetes Treatment Satisfaction Questionnaire
Time Frame: over a 2-4 week period
|
over a 2-4 week period
|
|
Scale (1-4) with questionnaire on anxiety (six-item short form STAI)
Time Frame: over a 2-4 week period
|
over a 2-4 week period
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The prevalence of GDM based on the IADPSG criteria
Time Frame: at 24-28 weeks of pregnancy
|
at 24-28 weeks of pregnancy
|
|
Composite endpoint of glycaemic control, weight, gestational weight gain and pregnancy outcomes
Time Frame: over a period of 16 weeks
|
over a period of 16 weeks
|
|
The frequency of insulin therapy for GDM
Time Frame: over a period of 16 weeks
|
over a period of 16 weeks
|
|
The time between the glucose challenge test and oral glucose tolerance test
Time Frame: at 24-28 weeks of pregnancy
|
at 24-28 weeks of pregnancy
|
|
The frequency of an HbA1c ≥6.5%
Time Frame: at 24-28 weeks of pregnancy
|
at 24-28 weeks of pregnancy
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 1, 2015
Primary Completion (Actual)
May 1, 2019
Study Completion (Actual)
June 1, 2019
Study Registration Dates
First Submitted
August 6, 2015
First Submitted That Met QC Criteria
August 17, 2015
First Posted (Estimate)
August 19, 2015
Study Record Updates
Last Update Posted (Actual)
November 4, 2020
Last Update Submitted That Met QC Criteria
November 3, 2020
Last Verified
November 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- the ELENA study
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.